Skip to content

Castle Biosciences CSTL Ratios & Valuation

FY'25FY'24FY'23FY'22
Profitability
Gross margin79.4%-2.5pp81.9%+2.3pp79.5%+2.9pp76.6%-6.5pp
Operating margin-12.4%-15.0pp2.6%+33.5pp-30.9%+22.2pp-53.2%-10.6pp
Net margin-7%-12.5pp5.5%+31.6pp-26.1%+22.8pp-49%-15.7pp
Returns
Return on equity-5.2%-9.5pp4.3%+18.8pp-14.5%+2.0pp-16.6%-9.0pp
Return on invested capital-11.4%-13.9pp2.6%+25.3pp-22.8%+15.6pp-38.3%
Efficiency
Asset turnover0.6×-0.1×0.7×+0.2×0.5×+0.2×0.3×+0.1×
Liquidity
Current ratio5.3×-2.0×7.3×+1.1×6.2×-1.9×8.1×-6.1×
Leverage
Debt-to-equity0.1×0.0×0.1×0.0×0.0×0.0×
Per Share
Book value per share$16.24+4.3%$15.58+6.7%$14.60-4.7%$15.32-6.5%
Valuation
Market capitalization$694.86M+29.9%$746.39M+28.5%$580.73M-6.4%$620.32M-42.8%
Price / sales+0.5×2.2×-0.4×2.6×-1.9×4.5×-7.0×
Price / book1.5×+0.3×1.6×+0.2×1.5×-0.1×1.6×-1.1×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Castle Biosciences's profit margins?
Castle Biosciences (CSTL) runs a 77.9% gross margin and a -9.8% operating margin, with a -3.8% net margin.
Where do Castle Biosciences's ratios come from?
Every ratio is computed from Castle Biosciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.